Dual HDAC/PI3K Inhibitors Trigger Apoptosis in p53-Mutant Lymphoma
In a groundbreaking study set to redefine therapeutic strategies in oncology, researchers have unveiled a potent combination therapy targeting p53-mutant ...
In a groundbreaking study set to redefine therapeutic strategies in oncology, researchers have unveiled a potent combination therapy targeting p53-mutant ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine